Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi |
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
- Adult hospital admissions associated with multiple sclerosis in Finland in 2004-2014 (2018)
- Annals of Medicine
- Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections (2018)
- Multiple Sclerosis and Related Disorders
- Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials (2018)
- Journal of Neurology
- Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab (2018)
- Neurology
- Monoklonaaliset vasta-aineet MS-taudin hoidossa (2018)
- Duodecim
- 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort (2017)
- Neurology
- Admission sodium level and prognosis in adult Guillain-Barré syndrome (2017)
- International Journal of Neuroscience
- Epidemiology of Guillain-Barré syndrome in Finland 2004–2014 (2017)
- Journal of the Peripheral Nervous System
- MS-taudin lääkehoito on uudessa murroksessa (2017)
- Sic! : lääketietoa Fimeasta
- National Finnish Treatment Register for MS patients - first results (2017)
- Multiple Sclerosis
